Pharmacy
Biden Administration Could Reclassify Marijuana as Less Risky Drug
SARS-CoV-2 Vaccine Does Not Increase New-Onset Seizure Risk
Findings compared with placebo at 28-day and 43-day follow-up
Cognitive Impairment Still Seen in Children, Teens With HIV
Impairments seen in processing speed, working memory, even in antiretroviral therapy era
Reduced Vancomycin Susceptibility Tied to Poorer C. Diff Outcomes
Poorer outcomes seen for 30-day sustained clinical response and 14-day initial cure rates
Semaglutide Alleviates Metabolic-Linked Liver Disease in People With HIV
29 percent of participants had complete resolution of metabolic-associated steatotic liver disease
FDA Approves New Antibiotic for Uncomplicated Urinary Tract Infections
Approval of Pivya is for female adults with UTIs caused by susceptible isolates of E. coli, P. mirabilis, and S. saprophyticus
Multisite QI Collaborative Increases Appropriate Pediatric Antibiotic Use
Increase seen in median adherence to empirical, definitive, and duration of antibiotic therapy during intervention period
Cabozantinib Promising for Metastatic Pheochromocytomas, Paragangliomas
Overall response rate was 25.0 percent in phase 2 study involving 17 patients
Warning Letters Can Reduce Quetiapine Overprescribing
Letters reduce quetiapine use among nursing home patients, community-dwelling patients with dementia
People With Acute Calcium Pyrophosphate Face Doubled Risk for Fracture
Findings seen for first fracture at the humerus, wrist, hip, or pelvis
